EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, IRIDEX's enterprise value is $48.86 Mil.
IRIDEX's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $51.87 Mil. Therefore, IRIDEX's EV-to-Revenue for today is 0.94.
The historical rank and industry rank for IRIDEX's EV-to-Revenue or its related term are showing as below:
IRIX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.23 Med: 1.43 Max: 3.37
Current: 0.94
During the past 13 years, the highest EV-to-Revenue of IRIDEX was 3.37. The lowest was 0.23. And the median was 1.43.
IRIX's EV-to-Revenue is ranked better than 83.27% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 2.95
vs IRIX: 0.94
As of today (2024-04-17), IRIDEX's stock price is $3.18.
IRIDEX's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.22. Therefore, IRIDEX's PS Ratio for today is 0.99.
IRIDEX EV-to-Revenue Historical Data
The historical data trend for IRIDEX's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
IRIDEX Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
0.49
0.76
1.41
0.35
0.80
IRIDEX Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
0.35
0.40
0.47
0.66
0.80
Competitive Comparison
For the Medical Devices subindustry, IRIDEX's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IRIDEX EV-to-Revenue Distribution
For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where IRIDEX's EV-to-Revenue falls into.
IRIDEX's current Enterprise Value is $48.86 Mil.
IRIDEX's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $51.87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRIDEX's share price for today is $3.18.
IRIDEX's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRIDEX EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of IRIDEX's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IRIX has been successfully added to your 